← Evidence map

ArticlePharmaceutics2020

Trans-Resveratrol Oral Bioavailability in Humans Using LipiSperse™ Dispersion Technology.

David Briskey et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

15 papers cite it

2020
2021
2022
2023
2024
2025
2026
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 33302446